So from this what do you presume is the effect of 6 to 12 mgs of cabergoline over a period of 4 months?Cabergoline-induced tricuspid regurgitation: Case report and review of literature - PMC
The increased risk of cardiac valve disease in patients treated for Parkinson's disease with cabergoline has raised concerns about the safety of treatment with ergot-derived dopamine agonists in patients with endocrine diseases, especially ...www.ncbi.nlm.nih.gov
Valvular heart disease and the use of dopamine agonists for Parkinson's disease - PubMed
The frequency of clinically important valve regurgitation was significantly increased in patients taking pergolide or cabergoline, but not in patients taking non-ergot-derived dopamine agonists, as compared with control subjects. These findings should be considered in evaluating the risk-benefit...pubmed.ncbi.nlm.nih.gov
Dopamine agonists and the risk of cardiac-valve regurgitation - PubMed
In this study, use of the dopamine agonists pergolide and cabergoline was associated with an increased risk of newly diagnosed cardiac-valve regurgitation.pubmed.ncbi.nlm.nih.gov